Medicines Promotion: Assessing the Nature, Extent and Impact of Regulation

Developed by: Health Action International (HAI) / MeTA

Objective: To determine the scope of regulation which covers pharmaceutical promotion and the impact and effectiveness of the regulatory framework on promotional practice.

Output:  A report that provides an overview of the national regulatory framework - including any gaps that need to be addressed and examples of unethical promotion - and assesses key stakeholders perceptions of the regulatory situation regarding medicines promotion.          

Additional information: This is a new, experimental tool. Even though it will be refined over the coming years, it is already useful in its current form, and available for field testing. It complements the World Health Organizations (WHO) Ethical Criteria for Medicinal Drug Promotion. To pilot the tool and for further information contact HAI Global on e-mail: .

Link to the tool:

Blue tablets